Antagonistic activity of 24-oxa-analogs of vitamin D

24-Oxa-vitamin D 3 (24-oxa-D 3) and 24-oxa-1α-hydroxyvitamin D 3 were designed as possible inhibitors of the vitamin D metabolic activation pathway. Their affinity for the vitamin D receptor (from pig intestine) and human vitamin binding protein were reduced, and their potency to induce cell differentiation of human leukemia cells (HL 60) or osteosarcoma cells (MG 63) was markedly reduced (19% and 3%, respectively), in comparison with calcitriol. A single or chronic injection of 24-oxa-D 3 had no biological activity, whereas chronic administration of 24-oxa-1α-hydroxy-D 3 showed weak agonist activity in rachitic chicks. When the 24-oxa-D 3 was given prior to a single injection of vitamin D 3, lower values of serum calcium (64% of the value obtained in vitamin D—treated animals), osteocalcin (52%), 25-(OH)D 3 (45%) and duodenal calbindin-D 28K (9.4%) were found. When given chronically in a 100-fold more excess no clear antagonistic effects were observed. 24-Oxa-D 3 is thus a new metabolic weak antagonist of vitamin D 3, but adding a hydroxyl group at C-1 creates a weak agonist.